Evidence-Based Research

Rigorous science.
Real outcomes.

LUCID's technology is built on peer-reviewed research and clinical evidence. We partner with leading institutions to validate the safety and efficacy of AI-driven audio interventions across health, wellness, and human performance.

Validated With

Our Research Partners

Clinically Validated

Our Published Research

Our latest study found that just 24 minutes of listening to specially designed music combined with auditory beat stimulation (ABS) can significantly reduce anxiety.

You can read our paper in PLOS ONE: Investigating the dose-response relationship between music and anxiety reduction: A randomized clinical trial
Read the study
This paper outlines plans to develop a digital therapeutic using AI-personalized music for people living with Alzheimer's.

You can read our paper in Frontiers in Digital Health: Developing a music based digital therapeutic to help manage the neuropsychiatric symptoms of dementia
Read the paper

Our latest clinical trial found our treatment integrating music and ABS to be effective in reducing state anxiety in a patient group.

You can read our study in PLOS ONE: The effects of music & auditory beat stimulation on anxiety: A randomized clinical
trial
Read the study

Why this matters.

Sound-based interventions address a critical gap: the need for effective, accessible, and scalable tools without the side effects of traditional treatments.

0%
of North Americans
affected by anxiety
0x
people prefer music over
meditation for relief
0%
anxiety reduction from
a single LUCID session
$0T
global wellness
market opportunity

Backed by Science

Science is at the centre of all we do. We’re glad to be contributing at the forefront of research into the health benefits of music. Read our library of scientific literature from leading researchers.
Read more
Music as Medicine: LUCID's Science + Technology White Paper
Read now
LUCID's Digital Music Therapy vs. Generic Functional Music & Self-Selected Music
Read now
Music to reduce pain and stress in the paediatric emergency department
Read more
Music interventions for improving psychological and physical outcomes in cancer patients
Read more
Effects of music therapy on occupational stress and burn-out risk of operating room staff
Read more

Our Experts

Our highest priority is to help people effectively manage and maintain their emotional wellbeing using a tool they know and love: music. We are proud to work with leading researchers to conduct rigorous studies, thus setting a high bar for our technology’s performance.

Dr. Frank Russo

Chief Science Officer
As Chief Science Officer, Dr. Frank A. Russo, Ph.D. leads LUCID's efforts to broaden and adapt its Digital Music Therapy technology into new therapeutic domains. Dr. Russo is Professor of Psychology and the NSERC-Sonova Senior Industrial Research Chair in Auditory Cognitive Neuroscience at Ryerson University. He is also Status Professor of Speech Language Pathology and Music, University of Toronto; Affiliate Research Scientist at Toronto Rehabilitation Institute; and Research Affiliate at McMaster Institute for Music and the Mind. At Ryerson's SMART Lab, Russo conducts research on the biological, cognitive, and social-emotional bases of music and speech. He is a Fellow of the Canadian Psychological Association and Massey College, and is a past president of the Canadian Acoustical Association. He currently serves as Associate Editor (Frontiers in Emotion Science; Music Perception); and is Past Editor-in-Chief (Canadian Acoustics).

Dr. Sageev Oore

Head of Machine Learning
As LUCID’s Head of Machine Learning, Dr. Sageev Oore advises on the application of artificial intelligence into the field of music for therapeutic outcomes. Dr. Sageev Oore is the Canada CIFAR AI Chair and a Research Faculty Member at the Vector Institute. He is an associate professor of Computer Science at Dalhousie University, where his research interests include machine learning and deep learning, with an emphasis on music, audio processing & creative applications. Dr. Oore was a Visiting Research Scientist at Google Brain, working on the Magenta Project and developing generative music systems such as PerformanceRNN. He is also an award-winning musician, studying piano performance with music teachers from Dalhousie, Juilliard, and UBC.

Dr. Rebecca Kleinberger

Voice Technology Expert, MIT
Dr. Rebecca Kleinberger is a voice expert and a researcher at the McGovern Institute/Media Lab at MIT. Her work spans from assistive technologies to vocal experiences design. Her research connects various fields, including sensor technologies, wearable computing, design, HCI, neurology, clinical research, and psychology. Kleinberger has developed unique expertise in the study, analysis, and understanding of the human voice. Her research aspiration is to create more healthy and meaningful technologies with and for the voice. She received a Masters in Media Arts and Sciences from MIT, a Masters in Virtual Environment and Computer Graphics from UCL in London, and a Masters in Mechanical Engineering from ENSAM Paris.

Dan McClure

Finance & Investments Advisor
Dan McClure is a financial industry veteran, spending over 20 years in the capital markets, and has executive experience in media.  He is currently Co-founder and Principal at Blue Deer Capital and previously was the president of Bron Studios.
He previously served as Head of Research at I.G. Investment Management, a $100B+ asset manager, and CEO & CIO of alternative manager, CQI Capital Management. As a portfolio manager, Mr. McClure managed over $3 billion of private and public assets. He has designed and launched four separate investment funds and is an active angel investor.

Dr. Farooq Naeem

Psychiatry Advisor, Chief of General and Health Systems Psychiatry CAMH
Dr. Farooq Naeem is the Chief of General and Health Systems Psychiatry at CAMH and professor of Psychiatry at the University of Toronto.
He has pioneered techniques for culturally adapting CBT. These techniques have been used to adapt CBT for a variety of common and severe mental health problems in South Asia, North Africa, the Middle East and China. He is considered a leader in global mental health.

Beverly Dywan

Experience Design Consultant
Beverly Dywan is a design consultant, and educator at OCAD University in Industrial Design and Inclusive Design. She also serves on the University’s Senate. Additionally, she has been a consultant to the Toronto Rehab Institute, providing a window onto their research and innovation.
Beverly has extensive international experience working with cultural institutions. Her company Design in Three Dimensions has provided experience and exhibit design, as well as strategic planning work for museums in Canada, the United States, and Hong Kong.